Valued at a market cap of $9.4 billion, Alexandria Real Estate Equities, Inc. (ARE) is a leading life science REIT company that pioneered the life science real estate niche and develops premier Mega campus ecosystems in top U.S. innovation hubs. It combines Class A/A+ properties with strategic venture capital to support life science innovation and deliver long-term value.
Shares of the Pasadena, California-based company have underperformed the broader market over the past 52 weeks. ARE stock has decreased 43.1% over this time frame, while the broader S&P 500 Index ($SPX) has rallied 12.6%. However, shares of ARE are up 11.4% on a YTD basis, outpacing SPX’s marginal gain.
